The Muller Group has appointed Dr Christian Heuer as new chief operating officer of Müller AG Cleaning Solutions.
The Müller Group, a supplier of packaging, product handling, and cleaning systems mainly for pharmaceutical production, announced that it has appointed Dr Christian Heuer as new chief operating officer of Müller AG Cleaning Solutions. Long-standing managing director, Ruedi Peterhans, will focus on marketing and sales.
Heuer will be responsible for further developing the Systems/Handling/Cleaning business unit for pharmaceutical, cosmetic and food industry. With a chemical engineering doctorate from the Technical University of Berlin, Heuer brings on board his long-term international experience in the pharmaceutical market, particularly in cleaning and sterilization technology. He was previously responsible for global sales and marketing at the Belimed Group.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.